Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Susan Chang, MD

Photo of Susan Chang, MD
Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
Address505 Parnassus Avenue, #M774B
San Francisco CA 94117
Phone415-353-7500
vCardDownload vCard
    Other Positions
    Title(s)Endowed Professor for the Neuro-Oncology Caregiver Program

    Title(s)Lai Wan Kan Endowed Chair

    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse education and training
    University of British ColumbiaM.D.1985School of Medicine
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse overview
    Susan Chang, MD
    Professor in Residence
    Lai Wan Kan Endowed Chair
    Division of Neuro-Oncology
    Program Co-Leader, UCSF Comprehensive Cancer Center
    Director, UCSF Neuro-Oncology Gordon Murray Caregiver Program
    Co-Director of the Sheri Sobrato Brain Cancer Survivorship Program
    Principal Investigator, Brain Tumor Research Center
    Collapse Academic Senate

    Collapse Research 
    Collapse research activities and funding
    Glioblastoma Therapeutics Network
    NIH/NCI UCA264338AJul 1, 2021 - Jun 30, 2026
    Role: Administrative and Clinical Core Co Investigator
    Description: Advancing treatment and understanding of immunotherapy in glioblastoma;
    Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma
    NIH P01CA118816Dec 1, 2005 - Jul 31, 2024
    Role: Principal Investigator
    Brain Tumor SPORE Grant
    NIH P50CA097257Sep 20, 2002 - Aug 31, 2023
    Role: Co-Investigator
    NCI Comprehensive Cancer Center Grant
    NIH/NCI P30 CA082103-17Aug 5, 1999 - Jul 31, 2023
    Role: Program Co-leader
    Description: Neurologic Oncology Program

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report. Neuro Oncol. 2025 Oct 14; 27(9):2209-2224. van den Bent MJ, Vogelbaum MA, Cloughesy T, Galldiks N, Albert NL, Tonn JC, Avila E, Fangusaro J, Mirsky D, Sahgal A, Soffietti R, Karschnia P, Mehta M, Kim MM, Boele F, Huse JT, Nayak L, Lim-Fat MJ, le Rhun E, Desjardins A, Lee EQ, Chukwueke U, Koekkoek JAF, Mendoza T, Loughan AR, Budhu JA, Bakas S, Huang RY, Villanueva-Meyer JE, Leone JP, Okada H, Reardon DA, Bi WL, Wen PY, Chang SM. PMID: 40317212; PMCID: PMC12526114.
      View in: PubMed   Mentions:    Fields:    
    2. Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative. Neuro Oncol. 2025 Oct 14; 27(9):2399-2414. Asogwa OA, Dirven L, Walbert T, Armstrong TS, Arons D, van den Bent MJ, Blakeley J, Coomans MB, Brown PD, Bulbeck H, Chang SM, Coens C, Gilbert MR, Grant R, Jalali R, Koekkoek JAF, Panda PK, Leach D, Leeper H, Mendoza T, Nayak L, Oliver K, Reijneveld JC, Le Rhun E, Rubinstein L, Taylor JW, Weller M, Wen PY, Taphoorn MJB. PMID: 40293144; PMCID: PMC12526050.
      View in: PubMed   Mentions:    Fields:    
    3. Celebrating 30 years of the Society for NeuroOncology and its tremendous impact on the Journal. Neuro Oncol. 2025 Sep 08; 27(7):1667-1669. Chang SM. PMID: 40923242; PMCID: PMC12417826.
      View in: PubMed   Mentions:    Fields:    
    4. Clinical Translation of Hyperpolarized 13C Metabolic Probes for Glioma Imaging. AJNR Am J Neuroradiol. 2025 Sep 02; 46(9):1754-1764. Autry AW, Kim Y, Dang D, Chen HY, Slater JB, Bok RA, Xu D, Lupo JM, Gordon JW, Larson PEZ, Vigneron DB, Li Y, Chang SM. PMID: 40044455; PMCID: PMC12453463.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    5. Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium. Neuro Oncol. 2025 Aug 30. Bettegowda C, Noushmehr H, Affinito A, Ahluwalia MS, Ansorge O, Ayasoufi K, Bagley S, Barnholtz-Sloan J, Best M, Brandsma D, Brodie C, Brüning-Richardson A, Castro AV, Chang SM, Condorelli G, Daher A, Datta V, de Groot J, French P, Galanis E, Golebiewska A, Hamerlik P, Hanemann CO, Holdhoff M, Huse J, Khasraw M, LeBlang S, Melin B, Mouliere F, O'Leary C, Rak J, Ray A, Robinson S, Rominiyi O, Roncaroli F, Rudà R, Seoane J, Sol N, van den Bent MJ, Vogelbaum MA, Walbert T, Watts C, Weiss T, Weller M, Wen PY, Wykes V, Yip S, Short SC, Soffietti R. PMID: 40884415.
      View in: PubMed   Mentions:    Fields:    
    6. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions. Neuro Oncol. 2025 Aug 13. Wen PY, Weller M, Lee EQ, Touat M, Khasraw M, Rahman R, Platten M, Lim M, Winkler F, Horbinski C, Verhaak RGW, Huang RY, Ahluwalia MS, Albert NL, Tonn JC, Schiff D, Barnholtz-Sloan JS, Ostrom Q, Aldape KD, Batchelor TT, Bindra RS, Chiocca EA, Cloughesy TF, DeGroot JF, French P, Galanis E, Galldiks N, Gilbert MR, Hegi ME, Lassman AB, Le Rhun E, Mehta MP, Mellinghoff IK, Minniti G, Roth P, Sanson M, Taphoorn MJB, von Deimling A, Weiss T, Wick W, Zadeh G, Reardon DA, Chang SM, Short SC, van den Bent MJ, Preusser M. PMID: 40827022.
      View in: PubMed   Mentions: 2     Fields:    
    7. Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI. NPJ Digit Med. 2025 Aug 07; 8(1):508. Tran N, Luks TL, Li Y, Jakary A, Ellison J, Liu B, Adegbite O, Nair D, Kakhandiki P, Molinaro AM, Villanueva-Meyer JE, Butowski N, Clarke JL, Chang SM, Braunstein SE, Morin O, Lin H, Lupo JM. PMID: 40775041; PMCID: PMC12331921.
      View in: PubMed   Mentions:
    8. Author Correction: RANO criteria for response assessment of brain metastases based on amino acid PET imaging. Nat Med. 2025 Aug; 31(8):2816. Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, Koh ES, Law I, Le Rhun E, Mair MJ, Werner JM, Berghoff AS, Furtner J, Minniti G, Scott AM, Short SC, Ivanidze J, Johnson DR, Suchorska B, Tolboom N, Tonn JC, Verger A, Galanis E, Brastianos PK, Wen PY, Weller M, Lin NU, Preusser M. PMID: 40490563.
      View in: PubMed   Mentions: 1     Fields:    
    9. Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas. Lancet Oncol. 2025 Aug; 26(8):e436-e447. Galldiks N, Lohmann P, Aboian M, Barajas RF, Breen WG, Ivanidze J, Johnson DR, Kaufmann TJ, Kim MM, Mair MJ, Minniti G, Müther M, Nabavizadeh A, Palmer JD, Rudà R, Smits M, Tolboom N, Veldhuijzen van Zanten SEM, Veronesi MC, Werner JM, van den Bent M, Chang SM, Langen KJ, Law I, McConathy J, Mehta M, Preusser M, Short SC, Soffietti R, Vogelbaum M, Weller M, Wen PY, Tonn JC, Albert NL. PMID: 40744043.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective. Neuro Oncol. 2025 Jul 19. van den Bent MJ, Cloughesy TF, Ellingson BM, Allen JE, Blackman SC, Kieran MW, Tonn JC, Karschnia P, Wijnenga M, Pallud J, Young RJ, Huang RY, Mellinghoff IK, de Groot J, van der Hoorn A, Youssef G, Hervey-Jumper SL, Vogelbaum MA, Chang SM, Wen PY. PMID: 40692474.
      View in: PubMed   Mentions:    Fields:    
    11. The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro Oncol. 2025 Jun 21; 27(5):1135-1148. de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. PMID: 39723472; PMCID: PMC12187374.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER consortium. Neuro Oncol. 2025 Jun 21; 27(5):1149-1164. Gerritsen JKW, Karschnia P, Young JS, van den Bent MJ, Chang SM, Smith TR, Nahed BV, Rincon-Torroella J, Bettegowda C, Sanai N, Krieg SM, Maruyama T, Schucht P, Broekman MLD, Tonn JC, Wen PY, De Vleeschouwer S, Vincent AJPE, Hervey-Jumper S, Berger MS, Mekary RA, Molinaro AM. PMID: 39657588; PMCID: PMC12187369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group. Neuro Oncol. 2025 May 15; 27(4):1046-1060. Karschnia P, Young JS, Youssef GC, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, Teske N, Dietrich J, Weller M, Vogelbaum MA, van den Bent M, Beck J, Thon N, Gerritsen JKW, Hervey-Jumper S, Cahill DP, Chang SM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Huang RY, Wen PY, Berger MS, Molinaro AM, Tonn JC. PMID: 39492786; PMCID: PMC12083231.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. RANO criteria for response assessment of brain metastases based on amino acid PET imaging. Nat Med. 2025 May; 31(5):1424-1430. Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, Koh ES, Law I, Le Rhun E, Mair MJ, Werner JM, Berghoff AS, Furtner J, Minniti G, Scott AM, Short SC, Ivanidze J, Johnson DR, Suchorska B, Tolboom N, Tonn JC, Verger A, Galanis E, Brastianos PK, Wen PY, Weller M, Lin NU, Preusser M. PMID: 40341837.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples. Sci Adv. 2025 Mar 14; 11(11):eadn2830. Wang Q, Wang J, Mathur R, Youngblood MW, Jin Q, Hou Y, Stasiak LA, Luan Y, Zhao H, Hilz S, Hong C, Chang SM, Lupo JM, Phillips JJ, Costello JF, Yue F. PMID: 40073147; PMCID: PMC11900876.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Tumour-wide RNA splicing aberrations generate actionable public neoantigens. Nature. 2025 Mar; 639(8054):463-473. Kwok DW, Stevers NO, Etxeberria I, Nejo T, Colton Cove M, Chen LH, Jung J, Okada K, Lakshmanachetty S, Gallus M, Barpanda A, Hong C, Chan GKL, Liu J, Wu SH, Ramos E, Yamamichi A, Watchmaker PB, Ogino H, Saijo A, Du A, Grishanina NR, Woo J, Diaz A, Hervey-Jumper SL, Chang SM, Phillips JJ, Wiita AP, Klebanoff CA, Costello JF, Okada H. PMID: 39972144; PMCID: PMC11903331.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    17. Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival. Neurooncol Adv. 2025 Jan-Dec; 7(1):vdaf024. Rodriguez Almaraz E, Guerra GA, Al-Adli NN, Young JS, Dada A, Quintana D, Taylor JW, Oberheim Bush NA, Clarke JL, Butowski NA, de Groot J, Pekmezci M, Perry A, Bollen AW, Scheffler AW, Glidden DV, Phillips JJ, Costello JF, Chang EF, Hervey-Jumper S, Berger MS, Francis SS, Chang SM, Solomon DA. PMID: 40051658; PMCID: PMC11883348.
      View in: PubMed   Mentions:
    18. Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions. Neuro Oncol. 2025 Jan 12; 27(1):13-32. Lim-Fat MJ, Bennett J, Ostrom Q, Touat M, Franceschi E, Schulte J, Bindra RS, Fangusaro J, Dhall G, Nicholson J, Jackson S, Davidson TB, Calaminus G, Robinson G, Whittle JR, Hau P, Ramaswamy V, Pajtler KW, Rudà R, Foreman NK, Hervey-Jumper SL, Das S, Dirks P, Bi WL, Huang A, Merchant TE, Fouladi M, Aldape K, Van den Bent MJ, Packer RJ, Miller JJ, Reardon DA, Chang SM, Haas-Kogan D, Tabori U, Hawkins C, Monje M, Wen PY, Bouffet E, Yeo KK. PMID: 39441704; PMCID: PMC11726256.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    19. Investment in the team approach to enhance the Journal's impact. Neuro Oncol. 2025 Jan 12; 27(1):1-2. Chang SM. PMID: 39803944; PMCID: PMC11726238.
      View in: PubMed   Mentions:    Fields:    
    20. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105. Lucas CG, Al-Adli NN, Young JS, Gupta R, Morshed RA, Wu J, Ravindranathan A, Shai A, Oberheim Bush NA, Taylor JW, de Groot J, Villanueva-Meyer JE, Pekmezci M, Perry A, Bollen AW, Theodosopoulos PV, Aghi MK, Chang EF, Hervey-Jumper SL, Raleigh DR, Molinaro AM, Costello JF, Diaz AA, Clarke JL, Butowski NA, Phillips JJ, Chang SM, Berger MS, Solomon DA. PMID: 39560080; PMCID: PMC11726253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. Reply. AJNR Am J Neuroradiol. 2025 Jan 08; 46(1):221-222. Ellingson BM, Sanvito F, Pope WB, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Chang SM, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Wen PY, Vogelbaum MA, van den Bent M. PMID: 39730160; PMCID: PMC11735428.
      View in: PubMed   Mentions: 1     Fields:    
    22. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0. Eur J Nucl Med Mol Imaging. 2025 Apr; 52(5):1822-1839. Verger A, Tolboom N, Cicone F, Chang SM, Furtner J, Galldiks N, Gempt J, Guedj E, Huang RY, Johnson DR, Law I, Le Rhun E, Short SC, Bent MJVD, Weehaeghe DV, Vogelbaum MA, Wen PY, Albert NL, Preusser M. PMID: 39762634; PMCID: PMC11928372.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults. AJNR Am J Neuroradiol. 2024 Dec 09; 45(12):1846-1856. Ellingson BM, Sanvito F, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Pope WB, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Vogelbaum MA, van den Bent M, Chang SM, Wen PY. PMID: 38926092; PMCID: PMC11630866.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    24. Enhancing neuro-oncology care through equity-driven applications of artificial intelligence. Neuro Oncol. 2024 Nov 04; 26(11):1951-1963. Mehari M, Sibih Y, Dada A, Chang SM, Wen PY, Molinaro AM, Chukwueke UN, Budhu JA, Jackson S, McFaline-Figueroa JR, Porter A, Hervey-Jumper SL. PMID: 39159285; PMCID: PMC11534320.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice. Lancet Oncol. 2024 Nov; 25(11):e589-e601. Bakas S, Vollmuth P, Galldiks N, Booth TC, Aerts HJWL, Bi WL, Wiestler B, Tiwari P, Pati S, Baid U, Calabrese E, Lohmann P, Nowosielski M, Jain R, Colen R, Ismail M, Rasool G, Lupo JM, Akbari H, Tonn JC, Macdonald D, Vogelbaum M, Chang SM, Davatzikos C, Villanueva-Meyer JE, Huang RY, Response Assessment in Neuro Oncology (RANO) group. PMID: 39481415; PMCID: PMC12007431.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    26. Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements. Lancet Oncol. 2024 Nov; 25(11):e581-e588. Villanueva-Meyer JE, Bakas S, Tiwari P, Lupo JM, Calabrese E, Davatzikos C, Bi WL, Ismail M, Akbari H, Lohmann P, Booth TC, Wiestler B, Aerts HJWL, Rasool G, Tonn JC, Nowosielski M, Jain R, Colen RR, Pati S, Baid U, Vollmuth P, Macdonald D, Vogelbaum MA, Chang SM, Huang RY, Galldiks N, Response Assessment in Neuro Oncology (RANO) group. PMID: 39481414; PMCID: PMC12045294.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation. Neuro Oncol. 2024 09 05; 26(9):1557-1571. Familiar AM, Fathi Kazerooni A, Vossough A, Ware JB, Bagheri S, Khalili N, Anderson H, Haldar D, Storm PB, Resnick AC, Kann BH, Aboian M, Kline C, Weller M, Huang RY, Chang SM, Fangusaro JR, Hoffman LM, Mueller S, Prados M, Nabavizadeh A. PMID: 38769022; PMCID: PMC11376457.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group. Lancet Oncol. 2024 Sep; 25(9):e404-e419. Karschnia P, Gerritsen JKW, Teske N, Cahill DP, Jakola AS, van den Bent M, Weller M, Schnell O, Vik-Mo EO, Thon N, Vincent AJPE, Kim MM, Reifenberger G, Chang SM, Hervey-Jumper SL, Berger MS, Tonn JC. PMID: 39214112.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    29. Ongoing expansion of journal activities to meet the needs of stakeholders. Neuro Oncol. 2024 08 05; 26(8):1353-1354. Chang SM. PMID: 39103180; PMCID: PMC11300007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI Dataset. Radiol Artif Intell. 2024 07; 6(4):e230182. Fields BKK, Calabrese E, Mongan J, Cha S, Hess CP, Sugrue LP, Chang SM, Luks TL, Villanueva-Meyer JE, Rauschecker AM, Rudie JD. PMID: 38864741; PMCID: PMC11294954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro Oncol. 2024 06 03; 26(6):993-1011. Nayak L, Bettegowda C, Scherer F, Galldiks N, Ahluwalia M, Baraniskin A, von Baumgarten L, Bromberg JEC, Ferreri AJM, Grommes C, Hoang-Xuan K, Kühn J, Rubenstein JL, Rudà R, Weller M, Chang SM, van den Bent MJ, Wen PY, Soffietti R. PMID: 38598668; PMCID: PMC11145457.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Glioma. Nat Rev Dis Primers. 2024 May 09; 10(1):33. Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger G. PMID: 38724526.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    33. SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201). BMJ Open. 2024 04 29; 14(4):e082274. Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE. PMID: 38684246; PMCID: PMC11086386.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    34. Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study. Cancers (Basel). 2024 Apr 17; 16(8). Liu J, Jakary A, Villanueva-Meyer JE, Butowski NA, Saloner D, Clarke JL, Taylor JW, Oberheim Bush NA, Chang SM, Xu D, Lupo JM. PMID: 38672606; PMCID: PMC11049314.
      View in: PubMed   Mentions: 2  
    35. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort. Neuro Oncol. 2024 04 05; 26(4):596-608. Budhu JA, Chukwueke UN, Jackson S, Lee EQ, McFaline-Figueroa JR, Willmarth N, Dalmage M, Kawachi I, Arons D, Chang SM, Galanis E, Hervey-Jumper SL, Wen PY, Porter AB. PMID: 38071654; PMCID: PMC10995510.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. Neuro Oncol. 2024 04 05; 26(4):640-652. Appin CL, Hong C, Suwala AK, Hilz S, Mathur R, Solomon DA, Smirnov IV, Stevers NO, Shai A, Wang A, Berger MS, Chang SM, Phillips JJ, Costello JF. PMID: 38141254; PMCID: PMC10995505.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. Sci Rep. 2024 03 16; 14(1):6362. Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker PB, Naik A, Shai A, Phillips JJ, Chang SM, Wiita AP, Wells JA, Costello JF, Diaz AA, Okada H. PMID: 38493204; PMCID: PMC10944514.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    38. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group. Neuro Oncol. 2024 03 04; 26(3):584-586. Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Thon N, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC. PMID: 38164632; PMCID: PMC10911992.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas. Neuro Oncol. 2024 02 02; 26(2):335-347. Saijo A, Ogino H, Butowski NA, Tedesco MR, Gibson D, Watchmaker PB, Okada K, Wang AS, Shai A, Salazar AM, Molinaro AM, Rabbitt JE, Shahin M, Perry A, Clarke JL, Taylor JW, Daras M, Oberheim Bush NA, Hervey-Jumper SL, Phillips JJ, Chang SM, Hilf N, Mayer-Mokler A, Keler T, Berger MS, Okada H. PMID: 37758193; PMCID: PMC10836773.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    40. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024 01 18; 187(2):446-463.e16. Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y, Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H, Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello JF. PMID: 38242087; PMCID: PMC10832360.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    41. Advanced Hyperpolarized 13C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach. Cancers (Basel). 2024 Jan 13; 16(2). Autry AW, Vaziri S, Gordon JW, Chen HY, Kim Y, Dang D, LaFontaine M, Noeske R, Bok R, Villanueva-Meyer JE, Clarke JL, Oberheim Bush NA, Chang SM, Xu D, Lupo JM, Larson PEZ, Vigneron DB, Li Y. PMID: 38254844; PMCID: PMC10814348.
      View in: PubMed   Mentions: 3  
    42. Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdad169. Smith EJ, Naik A, Goel M, Wen PY, Lim M, Chang SM, Germano IM. PMID: 38312230; PMCID: PMC10838133.
      View in: PubMed   Mentions: 3  
    43. RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future. Neuro Oncol. 2024 01 05; 26(1):2-4. Wen PY, van den Bent M, Vogelbaum MA, Chang SM. PMID: 37774741; PMCID: PMC10768981.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    44. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group. Neuro Oncol. 2024 01 05; 26(1):166-177. Karschnia P, Dietrich J, Bruno F, Dono A, Juenger ST, Teske N, Young JS, Sciortino T, Häni L, van den Bent M, Weller M, Vogelbaum MA, Morshed RA, Haddad AF, Molinaro AM, Tandon N, Beck J, Schnell O, Bello L, Hervey-Jumper S, Thon N, Grau SJ, Esquenazi Y, Rudà R, Chang SM, Berger MS, Cahill DP, Tonn JC. PMID: 37665776; PMCID: PMC10768992.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    45. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024 Jan; 25(1):e29-e41. Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. PMID: 38181810; PMCID: PMC11787868.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    46. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathol. 2023 12 11; 147(1):3. Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, Raleigh DR, Theodosopoulos P, Aghi MK, Chang EF, Hervey-Jumper SL, Costello JF, de Groot J, Butowski NA, Clarke JL, Chang SM, Berger MS, Molinaro AM, Solomon DA. PMID: 38079020; PMCID: PMC10713691.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    47. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. 2023 12 08; 25(12):2221-2236. Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C, Kim S, Yuan JB, Wu J, Barreto J, Lucas CG, Chan E, Pekmezci M, LeBoit PE, Mully T, Perry A, Bollen A, Van Ziffle J, Devine WP, Reddy AT, Gupta N, Basnet KM, Macaulay RJB, Malafronte P, Lee H, Yong WH, Williams KJ, Juratli TA, Mata DA, Huang RSP, Hiemenz MC, Pavlick DC, Frampton GM, Janovitz T, Ross JS, Chang SM, Berger MS, Jacques L, Song JS, Costello JF, Solomon DA. PMID: 37436963; PMCID: PMC10708934.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    48. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. Lancet Oncol. 2023 11; 24(11):e438-e450. Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M, Expert Rater Panel, von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. PMID: 37922934; PMCID: PMC10849105.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    49. Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Acta Neuropathol. 2023 12; 146(6):857-860. Terry M, Gupta R, Ravindranathan A, Wu J, Chan E, Bollen AW, Chang SM, Berger MS, Jacques L, Solomon DA. PMID: 37821623; PMCID: PMC10627975.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol. 2023 11 20; 41(33):5187-5199. Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM. PMID: 37774317; PMCID: PMC10860967.
      View in: PubMed   Mentions: 158     Fields:    Translation:Humans
    51. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group. Neuro Oncol. 2023 09 05; 25(9):1672-1685. Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC. PMID: 37253096; PMCID: PMC10479742.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    52. Hyperpolarized [2-13C]pyruvate MR molecular imaging with whole brain coverage. Neuroimage. 2023 10 15; 280:120350. Chung BT, Kim Y, Gordon JW, Chen HY, Autry AW, Lee PM, Hu JY, Tan CT, Suszczynski C, Chang SM, Villanueva-Meyer JE, Bok RA, Larson PEZ, Xu D, Li Y, Vigneron DB. PMID: 37634883; PMCID: PMC10530049.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas. Neuroimage Clin. 2023; 39:103501. Autry AW, Vaziri S, LaFontaine M, Gordon JW, Chen HY, Kim Y, Villanueva-Meyer JE, Molinaro A, Clarke JL, Oberheim Bush NA, Xu D, Lupo JM, Larson PEZ, Vigneron DB, Chang SM, Li Y. PMID: 37611371; PMCID: PMC10470324.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro Oncol. 2023 07 06; 25(7):1200-1224. Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC, Preusser M. PMID: 36843451; PMCID: PMC10326495.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    55. Increasing growth and impact of Neuro-Oncology. Neuro Oncol. 2023 07 06; 25(7):1199. Chang SM. PMID: 37416967; PMCID: PMC10326483.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro Oncol. 2023 06 02; 25(6):1017-1028. Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF. PMID: 36617262; PMCID: PMC10237425.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    57. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro Oncol. 2023 05 04; 25(5):940-954. Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Weller M, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Berger MS, Chang SM, van den Bent M, Tonn JC. PMID: 35961053; PMCID: PMC10158281.
      View in: PubMed   Mentions: 156     Fields:    Translation:Humans
    58. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro Oncol. 2023 01 05; 25(1):4-25. Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, Horbinski C, Huang RY, Jenkins RB, Ligon KL, Mellinghoff IK, Nabors LB, Platten M, Reardon DA, Shi DD, Schiff D, Wick W, Yan H, von Deimling A, van den Bent M, Kaelin WG, Wen PY. PMID: 36239925; PMCID: PMC9825337.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    59. Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac175. Avalos LN, Luks TL, Gleason T, Damasceno P, Li Y, Lupo JM, Phillips J, Oberheim Bush NA, Taylor JW, Chang SM, Villanueva-Meyer JE. PMID: 36479058; PMCID: PMC9721386.
      View in: PubMed   Mentions: 2  
    60. Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes. Neuro Oncol. 2022 10 03; 24(10):1749-1762. Zhang Y, Lucas CG, Young JS, Morshed RA, McCoy L, Oberheim Bush NA, Taylor JW, Daras M, Butowski NA, Villanueva-Meyer JE, Cha S, Wrensch M, Wiencke JK, Lee JC, Pekmezci M, Phillips JJ, Perry A, Bollen AW, Aghi MK, Theodosopoulos P, Chang EF, Hervey-Jumper SL, Berger MS, Clarke JL, Chang SM, Molinaro AM, Solomon DA. PMID: 35395677; PMCID: PMC9527525.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    61. TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac158. Karschnia P, Young JS, Dono A, Häni L, Juenger ST, Sciortino T, Bruno F, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, van den Bent M, Weller M, Berger MS, Chang SM, Tonn JC. PMID: 36325373; PMCID: PMC9616057.
      View in: PubMed   Mentions: 4  
    62. GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer. Cell Rep. 2022 09 20; 40(12):111344. McKinney AM, Mathur R, Stevers NO, Molinaro AM, Chang SM, Phillips JJ, Costello JF. PMID: 36130485; PMCID: PMC9534059.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    63. Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer. Nat Commun. 2022 09 16; 13(1):5430. Barger CJ, Suwala AK, Soczek KM, Wang AS, Kim MY, Hong C, Doudna JA, Chang SM, Phillips JJ, Solomon DA, Costello JF. PMID: 36114166; PMCID: PMC9481613.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    64. Building on the journal's success through collaboration and partnership. Neuro Oncol. 2022 09 01; 24(9):1407. Chang SM. PMID: 36048074; PMCID: PMC9435473.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-13C]pyruvate MRI data from patients with glioma. Neuroimage Clin. 2022; 36:103155. Vaziri S, Autry AW, Lafontaine M, Kim Y, Gordon JW, Chen HY, Hu JY, Lupo JM, Chang SM, Clarke JL, Villanueva-Meyer JE, Bush NAO, Xu D, Larson PEZ, Vigneron DB, Li Y. PMID: 36007439; PMCID: PMC9421383.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol. 2022 10; 144(4):747-765. Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, Samuel D, Brown M, Carmichael J, Lu R, Mirchia K, Sullivan DV, Pekmezci M, Tihan T, Bollen AW, Perry A, Banerjee A, Mueller S, Gupta N, Hervey-Jumper SL, Oberheim Bush NA, Daras M, Taylor JW, Butowski NA, de Groot J, Clarke JL, Raleigh DR, Costello JF, Phillips JJ, Reddy AT, Chang SM, Berger MS, Solomon DA. PMID: 35945463; PMCID: PMC9468105.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    67. Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. J Neurooncol. 2022 Aug; 159(1):43-52. Autry AW, Lafontaine M, Jalbert L, Phillips E, Phillips JJ, Villanueva-Meyer J, Berger MS, Chang SM, Li Y. PMID: 35672531; PMCID: PMC9325821.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    68. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Neuro Oncol. 2022 06 01; 24(6):855-871. Soffietti R, Bettegowda C, Mellinghoff IK, Warren KE, Ahluwalia MS, De Groot JF, Galanis E, Gilbert MR, Jaeckle KA, Le Rhun E, Rudà R, Seoane J, Thon N, Umemura Y, Weller M, van den Bent MJ, Vogelbaum MA, Chang SM, Wen PY. PMID: 34999836; PMCID: PMC9159432.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    69. Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. Neuro Oncol. 2022 04 01; 24(4):639-652. Cluceru J, Interian Y, Phillips JJ, Molinaro AM, Luks TL, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Shai A, Chunduru P, Pedoia V, Villanueva-Meyer JE, Chang SM, Lupo JM. PMID: 34653254; PMCID: PMC8972294.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    70. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. Clin Cancer Res. 2022 02 15; 28(4):594-602. Bagley SJ, Kothari S, Rahman R, Lee EQ, Dunn GP, Galanis E, Chang SM, Nabors LB, Ahluwalia MS, Stupp R, Mehta MP, Reardon DA, Grossman SA, Sulman EP, Sampson JH, Khagi S, Weller M, Cloughesy TF, Wen PY, Khasraw M. PMID: 34561269; PMCID: PMC9044253.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    71. Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. J Clin Invest. 2022 02 01; 132(3). Ogino H, Taylor JW, Nejo T, Gibson D, Watchmaker PB, Okada K, Saijo A, Tedesco MR, Shai A, Wong CM, Rabbitt JE, Olin MR, Moertel CL, Nishioka Y, Salazar AM, Molinaro AM, Phillips JJ, Butowski NA, Clarke JL, Oberheim Bush NA, Hervey-Jumper SL, Theodosopoulos P, Chang SM, Berger MS, Okada H. PMID: 34882581; PMCID: PMC8803342.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsPHPublic Health
    72. T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas. Front Neurol. 2021; 12:769345. Luks TL, Villanueva-Meyer JE, Weyer-Jamora C, Gehring K, Jakary A, Hervey-Jumper SL, Braunstein SE, Bracci PM, Brie MS, Smith EM, Chang SM, Taylor JW. PMID: 35153976; PMCID: PMC8831734.
      View in: PubMed   Mentions: 2  
    73. Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma. Neurosurgery. 2022 01 01; 90(1):124-130. Aabedi AA, Young JS, Zhang Y, Ammanuel S, Morshed RA, Dalle Ore C, Brown D, Phillips JJ, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J, Chang SM, Aghi M, Molinaro AM, Berger MS, Hervey-Jumper SL. PMID: 34982879; PMCID: PMC9514750.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    74. EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. Acta Neuropathol. 2022 01; 143(1):109-113. Lucas CG, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, Gener M, Ginn KF, Prall OWJ, Xu H, Kee D, Ko HS, Yaqoob N, Zia N, Florez A, Cha S, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA. PMID: 34825267; PMCID: PMC8732961.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    75. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 07; 32(4):e13037. Sloan EA, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Reddy A, Mueller S, Cho SJ, Horvai AE, Lee JC, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, von Deimling A, Chang SM, Berger MS, Solomon DA. PMID: 34821426; PMCID: PMC9245938.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    76. Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy. Neuro Oncol. 2021 11 02; 23(11):1974-1976. Lucas CG, Mueller S, Reddy A, Taylor JW, Oberheim Bush NA, Clarke JL, Chang SM, Gupta N, Berger MS, Perry A, Phillips JJ, Solomon DA. PMID: 34519829; PMCID: PMC8628364.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    77. Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. Neuro Oncol. 2021 11 02; 23(11):1872-1884. Yu Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S, Wahl M, Mazor T, Hong C, Shai A, Phillips JJ, Wainer BH, McDermott M, Haas-Kogan D, Taylor JW, Butowski N, Clarke JL, Berger MS, Molinaro AM, Chang SM, Costello JF, Oberheim Bush NA. PMID: 33823014; PMCID: PMC8563321.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    78. Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms. Hematol Oncol Clin North Am. 2022 02; 36(1):95-111. Mellinghoff IK, Chang SM, Jaeckle KA, van den Bent M. PMID: 34711457; PMCID: PMC9549919.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    79. Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasia. Neuro Oncol. 2021 10 01; 23(10):1798-1800. Wu J, Gupta R, Barreto J, Doo P, Joseph NM, Lee JC, Perry A, Chang SM, Berger MS, Solomon DA. PMID: 34351421; PMCID: PMC8485446.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    80. Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Neuro Oncol. 2021 08 02; 23(8):1252-1260. Lee EQ, Selig W, Meehan C, Bacha J, Barone A, Bloomquist E, Chang SM, de Groot JF, Galanis E, Hassan I, Kalidas C, Khasraw M, Kvedar JC, Lassman AB, Puduvalli V, Sahebjam S, Schwamm LH, Tamir S, Welch M, Yung WKA, Zadeh G, Arons D, Wen PY. PMID: 33822177; PMCID: PMC8083574.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    81. Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'. Acta Neuropathol. 2021 09; 142(3):595-599. Gupta R, Lucas CG, Wu J, Barreto J, Shah K, Simon IB, Casavilca-Zambrano S, Brathwaite C, Zhou H, Caccamo D, Gilani A, Kleinschmidt-DeMasters BK, Lee JC, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA. PMID: 34322742; PMCID: PMC8357689.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    82. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. J Immunother Cancer. 2021 07; 9(7). Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, Ashley DM, Wick W, Chang SM, Galanis E, Mansouri A, Khagi S, Mehta MP, Heimberger AB, Puduvalli VK, Reardon DA, Sahebjam S, Simes J, Antonia SJ, Berry D, Khasraw M. PMID: 34215688; PMCID: PMC8256733.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    83. Denoising of hyperpolarized 13 C MR images of the human brain using patch-based higher-order singular value decomposition. Magn Reson Med. 2021 11; 86(5):2497-2511. Kim Y, Chen HY, Autry AW, Villanueva-Meyer J, Chang SM, Li Y, Larson PEZ, Brender JR, Krishna MC, Xu D, Vigneron DB, Gordon JW. PMID: 34173268; PMCID: PMC8530853.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    84. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. J Neurooncol. 2021 Jul; 153(3):447-454. Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA. PMID: 34125374; PMCID: PMC8279971.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab035. Mrugala MM, Ostrom QT, Pressley SM, Taylor JW, Thomas AA, Wefel JS, Coven SL, Acquaye AA, Haynes C, Agnihotri S, Lim M, Peters KB, Sulman EP, Salcido JT, Butowski NA, Hervey-Jumper S, Mansouri A, Oliver KR, Porter AB, Nassiri F, Schiff D, Dunbar EM, Hegi ME, Armstrong TS, van den Bent MJ, Chang SM, Zadeh G, Chheda MG. PMID: 34007966; PMCID: PMC7928618.
      View in: PubMed   Mentions: 10  
    86. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Neurooncol Pract. 2021 Aug; 8(4):417-425. Dirven L, Vos ME, Walbert T, Armstrong TS, Arons D, van den Bent MJ, Blakeley J, Brown PD, Bulbeck H, Chang SM, Coens C, Gilbert MR, Grant R, Jalali R, Leach D, Leeper H, Mendoza T, Nayak L, Oliver K, Reijneveld JC, Le Rhun E, Rubinstein L, Weller M, Wen PY, Taphoorn MJB. PMID: 34277020; PMCID: PMC8278354.
      View in: PubMed   Mentions: 15  
    87. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 07; 31(4):e12918. Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Raffel C, Berger MS, Chang SM, Reddy A, Ramani B, Ferris SP, Lee JC, Hofmann JW, Cho SJ, Horvai AE, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, Solomon DA. PMID: 33141488; PMCID: PMC8089120.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    88. Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment. Neuro Oncol. 2020 12 18; 22(12):1822-1830. Huang RY, Young RJ, Ellingson BM, Veeraraghavan H, Wang W, Tixier F, Um H, Nawaz R, Luks T, Kim J, Gerstner ER, Schiff D, Peters KB, Mellinghoff IK, Chang SM, Cloughesy TF, Wen PY. PMID: 32328652; PMCID: PMC7746936.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    89. Neuro-Oncology Practice: Continuing to raise awareness of current practice and research opportunities in neuro-oncology. Neurooncol Pract. 2020 Dec; 7(6):581-582. Chang SM. PMID: 33312672; PMCID: PMC7716179.
      View in: PubMed   Mentions:
    90. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neuro Oncol. 2020 11 26; 22(11):1580-1590. Mathur R, Zhang Y, Grimmer MR, Hong C, Zhang M, Bollam S, Petrecca K, Clarke J, Berger MS, Phillips JJ, Oberheim-Bush NA, Molinaro AM, Chang SM, Costello JF. PMID: 32166314; PMCID: PMC8444710.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    91. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa142. Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, Perry A, Phillips JJ, Tihan T, Bollen AW, Pekmezci M, Butowski N, Oberheim Bush NA, Taylor JW, Chang SM, Theodosopoulos P, Aghi MK, Hervey-Jumper SL, Berger MS, Solomon DA, Clarke JL. PMID: 33354667; PMCID: PMC7739048.
      View in: PubMed   Mentions: 53  
    92. Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa124. Chen H, Kuhn J, Lamborn KR, Abrey LE, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WKA, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Wen PY, Gilbert MR. PMID: 33235994; PMCID: PMC7668489.
      View in: PubMed   Mentions: 11  
    93. Simultaneous multi-slice spin- and gradient-echo dynamic susceptibility-contrast perfusion-weighted MRI of gliomas. NMR Biomed. 2021 01; 34(1):e4399. Han M, Yang B, Fernandez B, Lafontaine M, Alcaide-Leon P, Jakary A, Burns BL, Morrison MA, Villanueva-Meyer JE, Chang SM, Banerjee S, Lupo JM. PMID: 32844496.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020 08 17; 22(8):1073-1113. Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ. PMID: 32328653; PMCID: PMC7594557.
      View in: PubMed   Mentions: 601     Fields:    Translation:Humans
    95. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa088. Jones LE, Hilz S, Grimmer MR, Mazor T, Najac C, Mukherjee J, McKinney A, Chow T, Pieper RO, Ronen SM, Chang SM, Phillips JJ, Costello JF. PMID: 32904945; PMCID: PMC7462278.
      View in: PubMed   Mentions: 18  
    96. Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma. Neuroimage Clin. 2020; 27:102323. Autry AW, Gordon JW, Chen HY, LaFontaine M, Bok R, Van Criekinge M, Slater JB, Carvajal L, Villanueva-Meyer JE, Chang SM, Clarke JL, Lupo JM, Xu D, Larson PEZ, Vigneron DB, Li Y. PMID: 32623139; PMCID: PMC7334458.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    97. Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13 C MRSI. Magn Reson Med. 2020 12; 84(6):3351-3365. Chen HY, Autry AW, Brender JR, Kishimoto S, Krishna MC, Vareth M, Bok RA, Reed GD, Carvajal L, Gordon JW, van Criekinge M, Korenchan DE, Chen AP, Xu D, Li Y, Chang SM, Kurhanewicz J, Larson PEZ, Vigneron DB. PMID: 32501614; PMCID: PMC7718428.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    98. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro Oncol. 2020 05 15; 22(5):601-612. Lee EQ, Weller M, Sul J, Bagley SJ, Sahebjam S, van den Bent M, Ahluwalia M, Campian JL, Galanis E, Gilbert MR, Holdhoff M, Lesser GJ, Lieberman FS, Mehta MP, Penas-Prado M, Schreck KC, Strowd RE, Vogelbaum MA, Walbert T, Chang SM, Nabors LB, Grossman S, Reardon DA, Wen PY. PMID: 31974566; PMCID: PMC7229255.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    99. Glioma patient-reported outcome assessment in clinical care - Authors' reply. Lancet Oncol. 2020 05; 21(5):e231. Armstrong TS, Chang SM, Jenkinson D, Kluetz P, Taphoorn MJB. PMID: 32359496.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020 02; 21(2):e97-e103. Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR, Jenkinson D, Kluetz P, Mendoza T, Rubinstein L, Sul J, Weller M, Wen PY, van den Bent MJ, Taphoorn MJB. PMID: 32007210.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    101. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdz048. Penas-Prado M, Wu J, Cahill DP, Brat DJ, Costello JF, Kluetz PG, Cairncross JG, van den Bent M, Verhaak RGW, Aboud O, Burger P, Chang SM, Cordova C, Huang RY, Rowe LS, Taphoorn MJB, Gilbert MR, Armstrong TS, NCI-CONNECT Oligodendroglioma Workshop . PMID: 33289010; PMCID: PMC7212866.
      View in: PubMed   Mentions: 7  
    102. The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. Cancer Discov. 2019 12; 9(12):1708-1719. Wang L, Babikir H, Müller S, Yagnik G, Shamardani K, Catalan F, Kohanbash G, Alvarado B, Di Lullo E, Kriegstein A, Shah S, Wadhwa H, Chang SM, Phillips JJ, Aghi MK, Diaz AA. PMID: 31554641; PMCID: PMC7161589.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCells
    103. Barriers to accrual and enrollment in brain tumor trials. Neuro Oncol. 2019 09 06; 21(9):1100-1117. Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY. PMID: 31175826; PMCID: PMC7594546.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    104. Letter: When Less is More: Dexamethasone Dosing for Brain Tumors. Neurosurgery. 2019 09 01; 85(3):E607-E608. Lim-Fat MJ, Bi WL, Lo J, Lee EQ, Ahluwalia MS, Batchelor TT, Chang SM, Chiocca EA, Chukwueke U, Cloughesy TF, Colman H, Deangelis LM, Galanis E, Gilbert MR, De Groot JF, Lassman AB, Liau LM, Mason W, McFaline-Figueroa JR, Mehta MP, Mellinghoff IK, Nabors LB, Nayak L, Reardon DA, Wen PY. PMID: 31215634; PMCID: PMC6904720.
      View in: PubMed   Mentions: 11     Fields:    
    105. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival. Neurooncol Pract. 2019 Sep; 6(5):364-374. Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE. PMID: 31555451; PMCID: PMC6753361.
      View in: PubMed   Mentions: 22  
    106. Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. Neuro Oncol. 2019 03 18; 21(4):424-427. Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, Sumrall A, Van den Bent M, Vogelbaum MA. PMID: 30883663; PMCID: PMC6422436.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    107. Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines. J Clin Oncol. 2019 05 01; 37(13):1130-1135. Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, Sumrall A, van den Bent M, Vogelbaum MA. PMID: 30883246; PMCID: PMC7098828.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    108. Two new initiatives and continuing concern for patient care and quality of life. Neurooncol Pract. 2019 Jan; 6(1):1-2. Chang SM. PMID: 31386056; PMCID: PMC6656318.
      View in: PubMed   Mentions:
    109. Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors. J Magn Reson Imaging. 2019 09; 50(3):868-877. Morrison MA, Hess CP, Clarke JL, Butowski N, Chang SM, Molinaro AM, Lupo JM. PMID: 30663150; PMCID: PMC6642688.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    110. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60. J Neurooncol. 2019 Jan; 141(2):383-391. Morshed RA, Han SJ, Hervey-Jumper SL, Pekmezci M, Troncon I, Chang SM, Butowski NA, Berger MS. PMID: 30498891.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    111. Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight. 2018 11 02; 3(21). Behr SC, Villanueva-Meyer JE, Li Y, Wang YH, Wei J, Moroz A, Lee JK, Hsiao JC, Gao KT, Ma W, Cha S, Wilson DM, Seo Y, Nelson SJ, Chang SM, Evans MJ. PMID: 30385712; PMCID: PMC6238742.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    112. Attitudes toward fertility and fertility preservation in women with glioma. Neurooncol Pract. 2019 May; 6(3):218-225. Stiner RK, Clarke JL, Sinha N, Chan J, Letourneau JM, Niemasik EE, Rabbitt JE, Chang SM, Butowski NA, Prados MD, Rosen MP. PMID: 31386027; PMCID: PMC6656302.
      View in: PubMed   Mentions: 6  
    113. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. J Neurooncol. 2018 Nov; 140(2):477-483. Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M. PMID: 30151703; PMCID: PMC6239922.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    114. Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro Oncol. 2018 06 18; 20(7):897-906. Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY. PMID: 29788429; PMCID: PMC6007454.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    115. Grade II and III Oligodendroglioma and Astrocytoma. Neurol Clin. 2018 08; 36(3):467-484. van den Bent MJ, Chang SM. PMID: 30072066.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    116. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol. 2018 04 09; 20(5):632-641. Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon DA, Costello JF. PMID: 29077933; PMCID: PMC5892142.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    117. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Rep. 2018 03 27; 22(13):3672-3683. Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR. PMID: 29590631; PMCID: PMC8204688.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    118. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol. 2018 01 10; 20(1):13-23. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Chamberlain MC, Packer RJ, Brandes AA, Reiss M, Goldman S, Fisher MJ, Pollack IF, Prados MD, Wen PY, Chang SM, Dufour C, Zurakowski D, Kortmann RD, Kieran MW. PMID: 28449033; PMCID: PMC5761545.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    119. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 2018 01; 19(1):e33-e42. Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. PMID: 29304360.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    120. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 2018 01; 19(1):e20-e32. Camidge DR, Lee EQ, Lin NU, Margolin K, Ahluwalia MS, Bendszus M, Chang SM, Dancey J, de Vries EGE, Harris GJ, Hodi FS, Lassman AB, Macdonald DR, Peereboom DM, Schiff D, Soffietti R, van den Bent MJ, Wefel JS, Wen PY. PMID: 29304358.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    121. Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma. Clin Cancer Res. 2018 01 15; 24(2):295-305. Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD. PMID: 29074604; PMCID: PMC7516926.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    122. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol. 2017 Dec; 10(6):895-903. Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. PMID: 28942218; PMCID: PMC5612804.
      View in: PubMed   Mentions: 10  
    123. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proc Natl Acad Sci U S A. 2017 10 03; 114(40):10743-10748. Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF. PMID: 28916733; PMCID: PMC5635900.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    124. Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE. Clin Cancer Res. 2018 02 15; 24(4):737-743. Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD, GBM AGILE Network. PMID: 28814435.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    125. Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiat Oncol. 2017 Aug 10; 12(1):126. Wahl M, Anwar M, Hess CP, Chang SM, Lupo JM. PMID: 28797254; PMCID: PMC5553662.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    126. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiat Res. 2017 09; 188(3):303-313. Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM. PMID: 28723274; PMCID: PMC5628052.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    127. Diffuse Infiltrating Oligodendroglioma and Astrocytoma. J Clin Oncol. 2017 Jul 20; 35(21):2394-2401. van den Bent MJ, Smits M, Kros JM, Chang SM. PMID: 28640702.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    128. Response Assessment in Neuro-Oncology Clinical Trials. J Clin Oncol. 2017 Jul 20; 35(21):2439-2449. Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ. PMID: 28640707; PMCID: PMC5516482.
      View in: PubMed   Mentions: 228     Fields:    Translation:Humans
    129. Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Sci Rep. 2017 03 22; 7:44792. Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ. PMID: 28327577; PMCID: PMC5361089.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    130. An expanding resource for the neuro-oncology community. Neurooncol Pract. 2017 Mar; 4(1):1-2. Chang SM. PMID: 31385991; PMCID: PMC6655343.
      View in: PubMed   Mentions:
    131. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemother Pharmacol. 2017 03; 79(3):603-610. Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD. PMID: 28233053.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    132. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. J Neurooncol. 2017 03; 132(1):171-179. Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ. PMID: 28124178; PMCID: PMC5373029.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    133. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas. J Neurooncol. 2017 03; 132(1):181-188. Nayak L, de Groot J, Wefel JS, Cloughesy TF, Lieberman F, Chang SM, Omuro A, Drappatz J, Batchelor TT, DeAngelis LM, Gilbert MR, Aldape KD, Yung AW, Fisher J, Ye X, Chen A, Grossman S, Prados M, Wen PY. PMID: 28116649; PMCID: PMC5588922.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    134. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J Oncol Pract. 2017 02; 13(2):123-127. Sulman EP, Ismaila N, Chang SM. PMID: 27907278.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    135. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J Clin Oncol. 2017 Jan 20; 35(3):361-369. Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM. PMID: 27893327.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    136. Creating a caregiver program in neuro-oncology. Neurooncol Pract. 2017 Jun; 4(2):116-122. Page MS, Chang SM. PMID: 31385965; PMCID: PMC6655409.
      View in: PubMed   Mentions: 9  
    137. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. J Neurooncol. 2016 10; 130(1):171-179. Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. PMID: 27535746; PMCID: PMC5069332.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    138. Laser Ablation vs Open Resection for Deep-Seated Tumors: The Case for Open Resection. Neurosurgery. 2016 08; 63 Suppl 1:10-14. Han SJ, Chang SM, Berger MS. PMID: 27399358.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    139. The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma. Acad Radiol. 2016 09; 23(9):1073-82. Barajas RF, Butowski NA, Phillips JJ, Aghi MK, Berger MS, Chang SM, Cha S. PMID: 27443507; PMCID: PMC5571825.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    140. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017 Jan; 40(1):1-14. Bush NA, Chang SM, Berger MS. PMID: 27085859.
      View in: PubMed   Mentions: 280     Fields:    Translation:HumansCells
    141. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro Oncol. 2016 08; 18(8):1169-79. Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. PMID: 26911151; PMCID: PMC4933480.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    142. Further collaboration and expansion of Neuro-Oncology Practice in 2016. Neurooncol Pract. 2016 Mar; 3(1):1-2. Chang SM. PMID: 31579515; PMCID: PMC6760347.
      View in: PubMed   Mentions:
    143. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol. 2016 Jan; 126(1):193-200. Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK, Tihan T, Barnes M, Mueller S, Butowski NA, Clarke JL, Chang SM, McDermott MM, Prados MD, Berger MS, Haas-Kogan DA. PMID: 26493740; PMCID: PMC4826306.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    144. Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine. Am Soc Clin Oncol Educ Book. 2016; 35:75-81. Chang SM, Cahill DP, Aldape KD, Mehta MP. PMID: 27249688.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    145. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015 Dec 15; 6(40):42468-77. Walsh KM, Codd V, Rice T, Nelson CP, Smirnov IV, McCoy LS, Hansen HM, Elhauge E, Ojha J, Francis SS, Madsen NR, Bracci PM, Pico AR, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Jenkins RB, Wiemels JL, Wiemels JL, ENGAGE Consortium Telomere Group, Samani NJ, Wiencke JK, Wrensch MR. PMID: 26646793; PMCID: PMC4767445.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    146. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Transl Oncol. 2015 Dec; 8(6):446-55. Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. PMID: 26692525; PMCID: PMC4700297.
      View in: PubMed   Mentions: 2  
    147. Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma. Neurooncol Pract. 2015 Dec; 2(4):205-209. Chang SM, Wen PY, Vogelbaum MA, Macdonald DR, van den Bent MJ. PMID: 31386074; PMCID: PMC6664617.
      View in: PubMed   Mentions: 13  
    148. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell. 2015 Sep 14; 28(3):307-317. Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers MLM, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Chang SM, Song JS, Costello JF. PMID: 26373278; PMCID: PMC4573399.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansCells
    149. Clinically feasible NODDI characterization of glioma using multiband EPI at 7 T. Neuroimage Clin. 2015; 9:291-9. Wen Q, Kelley DA, Banerjee S, Lupo JM, Chang SM, Xu D, Hess CP, Nelson SJ. PMID: 26509116; PMCID: PMC4579286.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    150. Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence. Neurosurgery. 2015 Aug; 62 Suppl 1:160-5. Han SJ, Englot DJ, Birk H, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA. PMID: 26181937; PMCID: PMC5260825.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    151. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372(26):2499-508. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. PMID: 26061753; PMCID: PMC4489704.
      View in: PubMed   Mentions: 1094     Fields:    Translation:HumansCells
    152. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015 Jun; 16(6):e270-8. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. PMID: 26065612.
      View in: PubMed   Mentions: 516     Fields:    Translation:Humans
    153. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 2015 May 29; 348(6238):1036-9. Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, Choi S, Hong C, He D, Pekmezci M, Wiencke JK, Wrensch MR, Chang SM, Walsh KM, Myong S, Song JS, Costello JF. PMID: 25977370; PMCID: PMC4456397.
      View in: PubMed   Mentions: 329     Fields:    Translation:HumansCells
    154. New initiatives for Neuro-Oncology Practice-building on the success of the first year. Neurooncol Pract. 2015 Mar; 2(1):1. Chang SM. PMID: 26034634; PMCID: PMC4369711.
      View in: PubMed   Mentions:
    155. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathol. 2015 Apr; 129(4):597-607. van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF. PMID: 25724300; PMCID: PMC4482618.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    156. Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma. Case Rep Radiol. 2015; 2015:731361. Barajas RF, Pampaloni MH, Clarke JL, Seo Y, Savic D, Hawkins RA, Behr SC, Chang SM, Berger M, Dillon WP, Cha S. PMID: 25793136; PMCID: PMC4352456.
      View in: PubMed   Mentions: 11  
    157. Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla. J Magn Reson Imaging. 2015 Aug; 42(2):269-79. Bian W, Banerjee S, Kelly DA, Hess CP, Larson PE, Chang SM, Nelson SJ, Lupo JM. PMID: 25471321; PMCID: PMC4876721.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    158. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol. 2015 Jan; 121(2):331-9. Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. PMID: 25351579; PMCID: PMC4311062.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    159. Impact of imaging measurements on response assessment in glioblastoma clinical trials. Neuro Oncol. 2014 Oct; 16 Suppl 7:vii24-35. Reardon DA, Ballman KV, Buckner JC, Chang SM, Ellingson BM. PMID: 25313236; PMCID: PMC4195531.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    160. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro Oncol. 2014 Oct; 16 Suppl 7:vii36-47. Wen PY, Cloughesy TF, Ellingson BM, Reardon DA, Fine HA, Abrey L, Ballman K, Bendszuz M, Buckner J, Chang SM, Prados MD, Pope WB, Gregory Sorensen A, van den Bent M, Yung WK. PMID: 25313237; PMCID: PMC4195530.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    161. Medical therapy of gliomas. J Neurooncol. 2014 Sep; 119(3):503-12. Ahluwalia MS, Chang SM. PMID: 24986089; PMCID: PMC4170021.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    162. A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma. Neuro Oncol. 2014 Jul; 16(7):984-90. Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD. PMID: 24637230; PMCID: PMC4057142.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    163. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014 Jul; 46(7):731-5. Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE, ENGAGE Consortium Telomere Group, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR. PMID: 24908248; PMCID: PMC4074274.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCells
    164. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma. Neuro Oncol. 2014 Sep; 16(9):1255-62. Han SJ, Rolston JD, Molinaro AM, Clarke JL, Prados MD, Chang SM, Berger MS, DeSilva A, Butowski NA. PMID: 24670608; PMCID: PMC4136897.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    165. Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy. NMR Biomed. 2014 May; 27(5):578-93. Elkhaled A, Jalbert L, Constantin A, Yoshihara HA, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. PMID: 24596146; PMCID: PMC3983568.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    166. Launch of Neuro-Oncology Practice. Neurooncol Pract. 2014 Mar; 1(1):1-2. Chang SM. PMID: 26034607; PMCID: PMC4369697.
      View in: PubMed   Mentions:
    167. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. Neuro Oncol. 2014 Apr; 16(4):567-78. Wen PY, Chang SM, Lamborn KR, Kuhn JG, Norden AD, Cloughesy TF, Robins HI, Lieberman FS, Gilbert MR, Mehta MP, Drappatz J, Groves MD, Santagata S, Ligon AH, Yung WK, Wright JJ, Dancey J, Aldape KD, Prados MD, Ligon KL. PMID: 24470557; PMCID: PMC3956354.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCTClinical Trials
    168. Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol. 2014 Jan; 16(2):274-9. Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT. PMID: 24335700; PMCID: PMC3895386.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    169. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10; 343(6167):189-193. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF. PMID: 24336570; PMCID: PMC3998672.
      View in: PubMed   Mentions: 781     Fields:    Translation:Humans
    170. Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology. 2014 Feb; 56(2):91-6. Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. PMID: 24281386; PMCID: PMC4940363.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansPHPublic Health
    171. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e407-16. Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. PMID: 23993385.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    172. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e396-406. Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. PMID: 23993384.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    173. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol. 2013 Aug; 15(8):1041-7. Walsh KM, Rice T, Decker PA, Kosel ML, Kollmeyer T, Hansen HM, Zheng S, McCoy LS, Bracci PM, Anderson E, Hsuang G, Wiemels JL, Pico AR, Smirnov I, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR. PMID: 23733245; PMCID: PMC3714154.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    174. Computer-aided detection of radiation-induced cerebral microbleeds on susceptibility-weighted MR images. Neuroimage Clin. 2013; 2:282-90. Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. PMID: 24179783; PMCID: PMC3777794.
      View in: PubMed   Mentions: 33     Fields:    
    175. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. Neuro Oncol. 2013 May; 15(5):607-17. Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ. PMID: 23393206; PMCID: PMC3635514.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    176. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro Oncol. 2013 Apr; 15(4):480-9. Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. PMID: 23393208; PMCID: PMC3607266.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    177. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol. 2013 May; 15(5):535-41. Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron A, Fink S, Kollmeyer T, Rynearson A, Voss J, Kosel ML, Fridley BL, Lachance DH, Eckel-Passow JE, Sicotte H, O'Neill BP, Giannini C, Wiencke JK, Jenkins RB, Wrensch MR. PMID: 23361564; PMCID: PMC3635511.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    178. Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am. 2013 Apr; 22(2):161-78. Huang T, Mueller S, Rutkowski MJ, Han SJ, Bloch O, Barani IJ, Parsa AT, Chang SM. PMID: 23453330.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    179. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM. J Magn Reson Imaging. 2013 Aug; 38(2):388-400. Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ. PMID: 23281184; PMCID: PMC3711964.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    180. Endpoints for clinical trials and revised assessment in neuro-oncology. Curr Opin Neurol. 2012 Dec; 25(6):780-5. Butowski N, Chang SM. PMID: 23007010.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    181. Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03. Clin Cancer Res. 2012 Nov 01; 18(21):6032-9. Lee EQ, Puduvalli VK, Reid JM, Kuhn JG, Lamborn KR, Cloughesy TF, Chang SM, Drappatz J, Yung WK, Gilbert MR, Robins HI, Lieberman FS, Lassman AB, McGovern RM, Xu J, Desideri S, Ye X, Ames MM, Espinoza-Delgado I, Prados MD, Wen PY. PMID: 22923449; PMCID: PMC3947570.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    182. Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res. 2013 Jan 01; 19(1):205-14. Crane CA, Han SJ, Ahn B, Oehlke J, Kivett V, Fedoroff A, Butowski N, Chang SM, Clarke J, Berger MS, McDermott MW, Prados MD, Parsa AT. PMID: 22872572.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCellsCTClinical Trials
    183. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol. 2012 Jul; 14(7):942-54. Barajas RF, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, Parsa AT, Aghi MK, McDermott MW, Berger MS, Cha S, Chang SM, Nelson SJ. PMID: 22711606; PMCID: PMC3379808.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    184. Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Apr; 69(4):920-30. Ozhinsky E, Vigneron DB, Chang SM, Nelson SJ. PMID: 22692829; PMCID: PMC3443494.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    185. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun 01; 18(11):3154-62. Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. PMID: 22472174; PMCID: PMC3607457.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    186. Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging. Transl Oncol. 2012 Feb; 5(1):10-8. Ozturk-Isik E, Pirzkall A, Lamborn KR, Cha S, Chang SM, Nelson SJ. PMID: 22348171; PMCID: PMC3281410.
      View in: PubMed   Mentions: 7  
    187. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery. 2012 Feb; 70(2):361-70. Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK. PMID: 21841523.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    188. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Sci Transl Med. 2012 Jan 11; 4(116):116ra5. Elkhaled A, Jalbert LE, Phillips JJ, Yoshihara HAI, Parvataneni R, Srinivasan R, Bourne G, Berger MS, Chang SM, Cha S, Nelson SJ. PMID: 22238333; PMCID: PMC3772177.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    189. General and neurological complications of targeted therapy. Handb Clin Neurol. 2012; 105:937-45. Butowski NA, Chang SM. PMID: 22230543.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    190. Recent medical management of glioblastoma. Adv Exp Med Biol. 2012; 746:26-40. Johnson DR, Chang SM. PMID: 22639157.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    191. Neuroimaging: diagnosis and response assessment in glioblastoma. Cancer J. 2012 Jan-Feb; 18(1):26-31. Clarke JL, Chang SM. PMID: 22290254.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    192. Current concepts in brain tumor imaging. Am Soc Clin Oncol Educ Book. 2012; 119-24. Norden AD, Pope WB, Chang SM. PMID: 24451720.
      View in: PubMed   Mentions: 4     Fields:    
    193. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery. 2012 Jan; 70(1):234-43; discussion 243-4. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM. PMID: 21593697.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    194. 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e493-500. Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ. PMID: 22000750; PMCID: PMC3268881.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansPHPublic Health
    195. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec; 13(12):1331-8. Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. PMID: 21896554; PMCID: PMC3223090.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsCTClinical Trials
    196. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro Oncol. 2011 Nov; 13(11):1192-201. Khayal IS, Vandenberg SR, Smith KJ, Cloyd CP, Chang SM, Cha S, Nelson SJ, McKnight TR. PMID: 21865401; PMCID: PMC3199150.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    197. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol. 2011 Oct; 13(10):1118-24. Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD, North American Brain Tumor Consortium. PMID: 21813511; PMCID: PMC3177665.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    198. A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival. J Neurosurg. 2011 Oct; 115(4):754-9. Kaur G, Bloch O, Jian BJ, Kaur R, Sughrue ME, Aghi MK, McDermott MW, Berger MS, Chang SM, Parsa AT. PMID: 21761969.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    199. Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. J Magn Reson Imaging. 2011 Apr; 33(4):808-16. McKnight TR, Smith KJ, Chu PW, Chiu KS, Cloyd CP, Chang SM, Phillips JJ, Berger MS. PMID: 21448944; PMCID: PMC3076678.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    200. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro Oncol. 2011 Mar; 13(3):280-9. Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg SR, Kelsey KT, Berger MS, Wiencke JK. PMID: 21339190; PMCID: PMC3064601.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    201. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol. 2011 Mar; 13(3):353-61. Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. PMID: 21310734; PMCID: PMC3064608.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    202. Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg. 2011 Jun; 114(6):1609-16. Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK. PMID: 21142749.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    203. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg. 2010 Aug; 113(2):301-9. Sampson JH, Archer G, Pedain C, Wembacher-Schröder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodríguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK, PRECISE Trial Investigators. PMID: 20020841.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    204. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg. 2011 Mar; 114(3):566-73. Chang EF, Clark A, Smith JS, Polley MY, Chang SM, Barbaro NM, Parsa AT, McDermott MW, Berger MS. PMID: 20635853; PMCID: PMC3877621.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    205. Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol. 2011 Jan; 101(2):267-77. Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM. PMID: 20563833; PMCID: PMC2996533.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    206. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg. 2010 May; 112(5):990-6. Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan T, McDermott MW, Berger MS, Chang SM, Parsa AT. PMID: 19817543.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    207. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010 Apr 10; 28(11):1963-72. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. PMID: 20231676.
      View in: PubMed   Mentions: 2021     Fields:    Translation:Humans
    208. Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study. Neuro Oncol. 2010 Jun; 12(6):608-13. Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, Musib L, Nicol SJ, Thornton DE, Prados MD. PMID: 20156802; PMCID: PMC2940647.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    209. Secondary gliosarcoma: a review of clinical features and pathological diagnosis. J Neurosurg. 2010 Jan; 112(1):26-32. Han SJ, Yang I, Tihan T, Chang SM, Parsa AT. PMID: 19408981.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    210. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. Neuro Oncol. 2010 Mar; 12(3):274-82. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. PMID: 20167815; PMCID: PMC2940590.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    211. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2009 Dec; 11(6):842-52. Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ. PMID: 19229057; PMCID: PMC2802404.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    212. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol. 2009 Dec; 2(4):271-80. Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. PMID: 19956389; PMCID: PMC2781083.
      View in: PubMed   Mentions: 21  
    213. 3D sensitivity encoded ellipsoidal MR spectroscopic imaging of gliomas at 3T. Magn Reson Imaging. 2009 Nov; 27(9):1249-57. Ozturk-Isik E, Chen AP, Crane JC, Bian W, Xu D, Han ET, Chang SM, Vigneron DB, Nelson SJ. PMID: 19766422; PMCID: PMC3022436.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    214. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. J Neurooncol. 2010 Mar; 97(1):33-40. McBride SM, Perez DA, Polley MY, Vandenberg SR, Smith JS, Zheng S, Lamborn KR, Wiencke JK, Chang SM, Prados MD, Berger MS, Stokoe D, Haas-Kogan DA. PMID: 19705067; PMCID: PMC2814032.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    215. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol. 2010 Jan; 96(2):211-7. Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY. PMID: 19562255; PMCID: PMC3786190.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    216. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol. 2009 Jun 20; 27(18):2905-8. van den Bent MJ, Vogelbaum MA, Wen PY, Macdonald DR, Chang SM. PMID: 19451418; PMCID: PMC2702230.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    217. Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol. 2009 May; 93(1):61-77. Plotkin SR, Halpin C, Blakeley JO, Slattery WH, Welling DB, Chang SM, Loeffler JS, Harris GJ, Sorensen AG, McKenna MJ, Barker FG. PMID: 19430883; PMCID: PMC4036446.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    218. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed. 2009 May; 22(4):449-55. Khayal IS, McKnight TR, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. PMID: 19125391; PMCID: PMC3772178.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    219. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol. 2009 May; 92(3):401-15. Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M. PMID: 19357966; PMCID: PMC2834319.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    220. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 01; 27(4):579-84. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. PMID: 19075262; PMCID: PMC2645859.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCTClinical Trials
    221. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. J Neurooncol. 2009 Feb; 91(3):337-51. Crawford FW, Khayal IS, McGue C, Saraswathy S, Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ. PMID: 19009235; PMCID: PMC3022444.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    222. Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol. 2009 Jun; 11(3):330-9. Liu R, Page M, Solheim K, Fox S, Chang SM. PMID: 19001097; PMCID: PMC2718978.
      View in: PubMed   Mentions: 109     Fields:    Translation:Humans
    223. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008 Nov; 109(5):817-24. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM. PMID: 18976070.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    224. A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas. J Neurooncol. 2009 Jan; 91(2):183-9. Butowski N, Lamborn KR, Lee BL, Prados MD, Cloughesy T, DeAngelis LM, Abrey L, Fink K, Lieberman F, Mehta M, Ian Robins H, Junck L, Salazar AM, Chang SM. PMID: 18850068; PMCID: PMC3104130.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    225. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn Reson Imaging. 2009 May; 27(4):480-8. Lupo JM, Banerjee S, Hammond KE, Kelley DA, Xu D, Chang SM, Vigneron DB, Majumdar S, Nelson SJ. PMID: 18823730; PMCID: PMC4905599.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    226. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). J Neurooncol. 2009 Jan; 91(2):175-82. Butowski N, Chang SM, Junck L, DeAngelis LM, Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD. PMID: 18797818; PMCID: PMC4779120.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    227. Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol. 2009 Feb; 11(1):59-68. Liu R, Solheim K, Polley MY, Lamborn KR, Page M, Fedoroff A, Rabbitt J, Butowski N, Prados M, Chang SM. PMID: 18713953; PMCID: PMC2718960.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    228. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro Oncol. 2008 Aug; 10(4):631-42. Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD, North American Brain Tumor Consortium. PMID: 18559968; PMCID: PMC2666238.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    229. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1340-6. Aiken AH, Chang SM, Larson D, Butowski N, Cha S. PMID: 18538496.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    230. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008 Mar 10; 26(8):1338-45. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. PMID: 18323558.
      View in: PubMed   Mentions: 421     Fields:    Translation:Humans
    231. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol. 2008 Apr; 10(2):162-70. Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD, North American Brain Tumor Consortium. PMID: 18356283; PMCID: PMC2613818.
      View in: PubMed   Mentions: 239     Fields:    Translation:Humans
    232. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008 Feb; 108(2):227-35. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS. PMID: 18240916.
      View in: PubMed   Mentions: 178     Fields:    Translation:Humans
    233. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 2008 Feb 15; 39(4):1682-92. Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. PMID: 18096412; PMCID: PMC2377156.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    234. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery. 2007 Nov; 61(5):1031-7; discussion 1037-8. Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, Lang FF, Croteau D, Parker K, Grahn AY, Sherman JW, Husain SR, Puri RK. PMID: 18091279.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    235. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neurooncol. 2007 Oct; 85(1):87-94. Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM. PMID: 17457513.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    236. Treatment for posterior fossa dissemination of primary supratentorial glioma. J Neurosurg. 2007 Apr; 106(4):567-74. Smith JS, Parney IF, Lamborn KR, McDermott MW, Sneed PK, Chang SM. PMID: 17432705.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    237. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol. 2007 Mar 01; 25(7):837-44. Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK, Cintredekin Besudotox Intraparenchymal Study Group. PMID: 17327604.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCTClinical Trials
    238. GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trials. J Neurooncol. 2007 Apr; 82(2):211-20. Chang S, Vogelbaum M, Lang FF, Haines S, Kunwar S, Chiocca EA, Olivi A, Quinones-Hinojosa A, Parsa A, Warnick R, American Association of Neurological Surgeons and Congress of Neurological Surgeons (AANS/CNS). PMID: 17146595.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    239. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol. 2007 Feb; 81(3):271-7. Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK. PMID: 17031561.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    240. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2006 Aug 01; 24(22):3651-6. Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD. PMID: 16877733.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    241. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg. 2006 Jul; 105(1):34-40. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, Berger MS. PMID: 16871879.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    242. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme. Neurosurg Focus. 2006 Apr 15; 20(4):E4. Chang SM, Butowski NA, Sneed PK, Garner IV. PMID: 16709035.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    243. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies. Neurosurg Focus. 2006 Apr 15; 20(4):E15. Kunwar S, Chang SM, Prados MD, Berger MS, Sampson JH, Croteau D, Sherman JW, Grahn AY, Shu VS, Dul JL, Husain SR, Joshi BH, Pedain C, Puri RK. PMID: 16709020.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    244. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006 Mar 10; 24(8):1273-80. Butowski NA, Sneed PK, Chang SM. PMID: 16525182.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    245. Does temsirolimus have a role in recurrent glioblastoma multiforme? Nat Clin Pract Oncol. 2006 Feb; 3(2):70-1. Chang SM. PMID: 16462841.
      View in: PubMed   Mentions:    Fields:    
    246. Glial tumors: the current state of scientific knowledge. Clin Neurosurg. 2006; 53:106-13. Butowski NA, Chang SM. PMID: 17380744.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    247. Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer. 2005 Nov 01; 104(9):1975-84. Chang SM, Barker FG. PMID: 16130137.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    248. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol. 2005 Oct; 7(4):425-34. Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, Bigner DD. PMID: 16212807; PMCID: PMC1871726.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    249. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg. 2005 Sep; 103(3):428-38. Smith JS, Cha S, Mayo MC, McDermott MW, Parsa AT, Chang SM, Dillon WP, Berger MS. PMID: 16235673.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    250. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs. 2005 Aug; 23(4):357-61. Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, De Angelis L, Raizer J, Hess K, Aldape K, Lamborn KR, Kuhn J, Dancey J, Prados MD, North American Brain Tumor Consortium and the National Cancer Institute. PMID: 16012795.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansCTClinical Trials
    251. A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. Int J Radiat Oncol Biol Phys. 2005 Apr 01; 61(5):1454-9. Butowski N, Prados MD, Lamborn KR, Larson DA, Sneed PK, Wara WM, Malec M, Rabbitt J, Page M, Chang SM. PMID: 15817350.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    252. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg. 2005 Apr; 102(4):622-8. Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM. PMID: 15871503.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    253. Small molecule and monoclonal antibody therapies in neurooncology. Cancer Control. 2005 Apr; 12(2):116-24. Butowski N, Chang SM. PMID: 15855895.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    254. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol. 2005 Apr; 26(4):760-9. Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Chang SM, Nelson SJ. PMID: 15814918; PMCID: PMC7977113.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    255. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005 Feb 02; 293(5):557-64. Chang SM, Parney IF, Huang W, Anderson FA, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER, Glioma Outcomes Project Investigators. PMID: 15687310.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    256. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg. 2005 Feb; 102(2):267-75. Parney IF, Kunwar S, McDermott M, Berger M, Prados M, Cha S, Croteau D, Puri RK, Chang SM. PMID: 15739554.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    257. Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs. 2004 Nov; 22(4):427-35. Chang SM, Kuhn J, Wen P, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, Cloughesy T, De Angelis L, Razier J, Hess K, Dancey J, Prados MD, North American Brain Tumor Consortium And The National Cancer Institute. PMID: 15292713.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    258. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):353-7. Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD. PMID: 15380566.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    259. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma. J Neurosurg. 2004 Sep; 101(3):467-75. Chan AA, Lau A, Pirzkall A, Chang SM, Verhey LJ, Larson D, McDermott MW, Dillon WP, Nelson SJ. PMID: 15352605.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    260. Brain metastases. Curr Probl Surg. 2004 Aug; 41(8):665-741. Shaffrey ME, Mut M, Asher AL, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB, Markert JM, Schiff D, Siomin V, Tatter SB, Vogelbaum MA. PMID: 15354117.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    261. Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1122-6. Chang SM, Seiferheld W, Curran W, Share R, Atkins J, Choucair A, Kresl J, Thoron L, Cairncross G, Gilbert M, Bahary JP, Dolinskas C, Louis DN, Bushunow P, Buckner J, Barger G, Mehta M. PMID: 15234047.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    262. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004 Jul; 6(3):227-35. Lamborn KR, Chang SM, Prados MD. PMID: 15279715; PMCID: PMC1871999.
      View in: PubMed   Mentions: 236     Fields:    Translation:Humans
    263. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer. 2004 Apr 15; 100(8):1712-6. Chang SM, Prados MD, Yung WK, Fine H, Junck L, Greenberg H, Robins HI, Mehta M, Fink KL, Jaeckle KA, Kuhn J, Hess K, Schold C. PMID: 15073861.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    264. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol. 2004 Apr; 6(2):119-26. Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK, Berger MS. PMID: 15134626; PMCID: PMC1871978.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    265. Temozolomide in the treatment of recurrent malignant glioma. Cancer. 2004 Feb 01; 100(3):605-11. Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. PMID: 14745879.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    266. Central neurocytoma: a review. J Neurooncol. 2004 Feb; 66(3):377-84. Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW. PMID: 15015671.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    267. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro Oncol. 2004 Jan; 6(1):33-7. Prados MD, Yung WK, Fine HA, Greenberg HS, Junck L, Chang SM, Nicholas MK, Robins HI, Mehta MP, Fink KL, Jaeckle KA, Kuhn J, Hess KR, Schold SC, North American Brain Tumor Consortium study. PMID: 14769138; PMCID: PMC1871975.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    268. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol. 2004 Jan; 6(1):44-54. Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J, North American Brain Tumor Consortium study. PMID: 14769140; PMCID: PMC1871968.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    269. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg. 2004 Jan; 100(1):41-6. Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS. PMID: 14743910.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    270. The role of PCV chemotherapy in the treatment of central neurocytoma: illustration of a case and review of the literature. Surg Neurol. 2003 Dec; 60(6):560-5. von Koch CS, Schmidt MH, Uyehara-Lock JH, Berger MS, Chang SM. PMID: 14670681.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    271. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. J Neurooncol. 2003 Dec; 65(3):269-78. Prados MD, McDermott M, Chang SM, Wilson CB, Fick J, Culver KW, Van Gilder J, Keles GE, Spence A, Berger M. PMID: 14682377.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsCTClinical Trials
    272. A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report. Invest New Drugs. 2003 Nov; 21(4):429-33. Chang SM, Kuhn JG, Ian Robins H, Clifford Schold S, Spence AM, Berger MS, Mehta MP, Pollack I, Gilbert M, Prados MD. PMID: 14586210.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    273. Intraventricular neurocytomas. Neurosurg Clin N Am. 2003 Oct; 14(4):483-508. Lee J, Chang SM, McDermott MW, Parsa AT. PMID: 15024797.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    274. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003 Jun; 98(6):1175-81. Chang SM, Parney IF, McDermott M, Barker FG, Schmidt MH, Huang W, Laws ER, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M, Glioma Outcomes Investigators. PMID: 12816260.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    275. Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg. 2003 Jun; 98(6):1165-9. Schmidt MH, Berger MS, Lamborn KR, Aldape K, McDermott MW, Prados MD, Chang SM. PMID: 12816258.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    276. Current chemotherapy for glioblastoma. Cancer J. 2003 May-Jun; 9(3):149-56. Parney IF, Chang SM. PMID: 12952300.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    277. Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery. 2002 Jul; 51(1):44-55; discussion 55-6. Lutterbach J, Fauchon F, Schild SE, Chang SM, Pagenstecher A, Volk B, Ostertag C, Momm F, Jouvet A. PMID: 12182434.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    278. Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer. 2002 May 15; 94(10):2681-7. Chang SM, Barker FG, Schmidt MH, Sloan AE, Kasper R, Phillips L, Shih K, Hariharan S, Berger MS. PMID: 12173337.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    279. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study. Neuro Oncol. 2002 Apr; 4(2):109-14. Robins HI, Chang SM, Prados MD, Yung WK, Hess K, Schiff D, Greenberg H, Fink K, Nicolas K, Kuhn JG, Cloughesy T, Junck L, Mehta M. PMID: 11916502; PMCID: PMC1920656.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    280. Multidisciplinary management of adult anaplastic astrocytomas. Semin Radiat Oncol. 2001 Apr; 11(2):163-9. Chang S, Theodosopoulos P, Sneed P. PMID: 11285554.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Susan's Networks
    Concepts (506)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (149)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.